Trending
Advertisement

Topic: Andrew von Eschenbach

Jump to
Latest Headlines Quotes

Andrew von Eschenbach News

Science News // 1 decade ago
FDA opens offices in China
The U.S. Food and Drug Administration opened three offices in China this week as part of an effort to improve the safety of food imported from the Asian nation.
Science News // 1 decade ago
FDA: Food protection plan shows progress
The U.S. Food and Drug Administration says its plan to keep U.S. citizens enjoying one of the safest food supplies in the world shows significant progress.
Science News // 1 decade ago
Frank Tori named FDA chief scientist
The U.S. Food and Drug Administration has appointed Dr. Frank Torti as its principal deputy commissioner and new chief scientist.
Science News // 1 decade ago
FDA names drug research chief
The U.S. Food and Drug Administration has selected Dr. Janet Woodcock to become the agency's director of drug evaluation and research.
Science News // 1 decade ago
FDA creates pediatric review committee
The U.S. Food and Drug Administration announced the creation Thursday of an internal pediatric review committee.
Science News // 1 decade ago
Masoudi named FDA associate counsel
Gerald Masoudi has been named associate general counsel of the food and drug division of the U.S. Department of Health and Human Services.
Science News // 1 decade ago
U.S. FDA, Chinese officials meet in China
U.S. Food and Drug Administration Commissioner Dr. Andrew von Eschenbach has met with Chinese health officials to discuss the safety of imports.
Science News // 1 decade ago
FDA proposes new sunscreen rules
The U.S. Food and Drug Administration issued a proposal Thursday setting standards for formulating, testing and labeling over-the-counter sunscreen products.
Science News // 1 decade ago
FDA urged to address nanotechnology safety
The U.S. Food and Drug Administration's Nanotechnology Task Force released a report Wednesday urging the agency consider addressing nanotechnology risks.
Top News // 1 decade ago
FDA requests diabetes drug warnings
The U.S. Food and Drug Administration is requesting safety warnings for diabetes drugs Avandia and Actos after they came under congressional scrutiny.


Quotes

The Food Protection Plan is the comprehensive framework the agency needs to enhance the protection of our nation's food supply

FDA: Food protection plan shows progress Jul 02, 2008

His leadership and service will be critical to FDA's public health mission and regulatory responsibilities

Masoudi named FDA associate counsel Oct 16, 2007

These labs form the backbone of FDA's work in ensuring the safety of food, medical equipment and cosmetics

Senators ask the FDA to halt lab closings Jan 30, 2007

The future will look no more like the past than a butterfly resembles a caterpillar

U.S. starts historic cancer genome project Dec 14, 2005

He understands that basic research is the foundation to any success in eliminating cancer, and that research breakthroughs must be translated into effective treatments for patients

Cancer survivor leads national institute Dec 06, 2001

Most Popular

Arizona grand jury charges 18 Trump allies in fake electors scheme
Arizona grand jury charges 18 Trump allies in fake electors scheme
IndyCar driver Newgarden disqualified as winner of St. Pete grand prix last month
IndyCar driver Newgarden disqualified as winner of St. Pete grand prix last month
Russia vetoes U.N. resolution opposing space-based nuclear arms
Russia vetoes U.N. resolution opposing space-based nuclear arms
North Korea warns of forceful response if U.S. tightens sanctions monitoring
North Korea warns of forceful response if U.S. tightens sanctions monitoring
Three cows lead Kansas police on hoof-chase
Three cows lead Kansas police on hoof-chase

Wiki

Andrew C. von Eschenbach (born October 30, 1941 in Philadelphia, Pennsylvania) was the Commissioner of the United States Food and Drug Administration from 2006-2009. He became acting Commissioner on September 26, 2005, after the resignation of his predecessor Lester Crawford, and was confirmed as Commissioner by the Senate on December 7, 2006. He was previously the 12th director of the National Cancer Institute.

After graduating from St. Joseph's Preparatory School, Von Eschenbach received his bachelor of science in biology from St. Joseph's University in 1963 and his MD from Georgetown University School of Medicine in 1967. He did residencies at Pennsylvania Hospital in general surgery and urology and taught urology at the University of Pennsylvania School of Medicine. He served in the US Navy Medical Corps with the rank of lieutenant commander from 1968 to 1971.

In 1976, von Eschenbach began his long association with The University of Texas M. D. Anderson Cancer Center, beginning as a urologic oncology fellow and becoming chair of the department of urology in 1983. He was founding director of the Prostate Cancer Research Program in 1996, director of the Genitourinary Cancer Center, and held the Roy M. and Phyllis Gough Huffington Clinical Research Distinguished Chair in Urologic Oncology. Driven by his father's prostate cancer, he specialized in the disease.

FULL ARTICLE AT WIKIPEDIA.ORG
This article is licensed under the GNU Free Documentation License.
It uses material from the Wikipedia article "Andrew von Eschenbach."